| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |